{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:52:50Z","timestamp":1783011170714,"version":"3.54.6"},"reference-count":18,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,20]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Complete or partial response at 1 year without secondary systemic treatment provides clinical benefit in patients with chronic GVHD. Success defined by this endpoint is currently observed in fewer than 20% of patients after initial systemic treatment of chronic GVHD.<\/jats:p>","DOI":"10.1182\/blood-2017-03-775767","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T21:00:20Z","timestamp":1494536420000},"page":"360-367","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":54,"title":["An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease"],"prefix":"10.1182","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-1215","authenticated-orcid":false,"given":"Paul J.","family":"Martin","sequence":"first","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E. D.","family":"Flowers","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Pediatrics, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Palmer","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Mayo Clinic, Phoenix, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Jagasia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University Medical Center, Stanford, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111903482005000_B1","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111903482005000_B2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111903482005000_B3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111903482005000_B4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/bmt.2013.48","article-title":"Characteristics of chronic GVHD after cord blood transplantation","volume":"48","author":"Newell","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111903482005000_B5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V97.5.1196","article-title":"How I treat chronic graft-versus-host disease","volume":"97","author":"Vogelsang","year":"2001","journal-title":"Blood"},{"issue":"4","key":"2019111903482005000_B6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111903482005000_B7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2019111903482005000_B8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbmt.2015.05.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. The 2014 Clinical Trial Design Working Group report","volume":"21","author":"Martin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"2019111903482005000_B9","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2012-11-465583","article-title":"Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111903482005000_B10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2014-03-563544","article-title":"Failure-free survival after initial systemic treatment of chronic graft-versus-host disease","volume":"124","author":"Inamoto","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111903482005000_B11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2014.117283","article-title":"Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease","volume":"100","author":"Palmer","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"2019111903482005000_B12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2019111903482005000_B13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbmt.2011.05.007","article-title":"Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD","volume":"17","author":"Chronic GVHD Consortium","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2019111903482005000_B14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111903482005000_B15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy\u2014Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2019111903482005000_B16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2019111903482005000_B17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/bmt.2016.131","article-title":"Confounding factors affecting the National Institutes of Health (NIH) chronic graft-versus-host disease organ-specific score and global severity","volume":"51","author":"Aki","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111903482005000_B18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2015-08-662874","article-title":"Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease","volume":"127","author":"Palmer","year":"2016","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/3\/360\/1404451\/blood775767.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/3\/360\/1404451\/blood775767.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:48:31Z","timestamp":1574135311000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/3\/360\/36898\/An-endpoint-associated-with-clinical-benefit-after"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-03-775767","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]}}}